Coronavirus Disease Outbreak in Call Center, South Korea

Emerg Infect Dis. 2020 Aug;26(8):1666-1670. doi: 10.3201/eid2608.201274. Epub 2020 Apr 23.

Abstract

We describe the epidemiology of a coronavirus disease (COVID-19) outbreak in a call center in South Korea. We obtained information on demographic characteristics by using standardized epidemiologic investigation forms. We performed descriptive analyses and reported the results as frequencies and proportions for categoric variables. Of 1,143 persons who were tested for COVID-19, a total of 97 (8.5%, 95% CI 7.0%-10.3%) had confirmed cases. Of these, 94 were working in an 11th-floor call center with 216 employees, translating to an attack rate of 43.5% (95% CI 36.9%-50.4%). The household secondary attack rate among symptomatic case-patients was 16.2% (95% CI 11.6%- 22.0%). Of the 97 persons with confirmed COVID-19, only 4 (1.9%) remained asymptomatic within 14 days of quarantine, and none of their household contacts acquired secondary infections. Extensive contact tracing, testing all contacts, and early quarantine blocked further transmission and might be effective for containing rapid outbreaks in crowded work settings.

Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; South Korea; call center; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

MeSH terms

  • Betacoronavirus / genetics
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • COVID-19 Testing
  • Call Centers
  • Clinical Laboratory Techniques / methods
  • Contact Tracing / statistics & numerical data
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / transmission*
  • Disease Outbreaks*
  • Family Characteristics
  • Female
  • Humans
  • Incidence
  • Male
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / transmission*
  • Quarantine / methods
  • Republic of Korea / epidemiology
  • Reverse Transcriptase Polymerase Chain Reaction
  • SARS-CoV-2
  • Severity of Illness Index